Thomas James Ihrke - Net Worth and Insider Trading
Thomas James Ihrke Net Worth
The estimated net worth of Thomas James Ihrke is at least $23,348 dollars as of 2024-05-01. Thomas James Ihrke is the Sr. VP, Business Development of Lexaria Bioscience Corp and owns about 7,556 shares of Lexaria Bioscience Corp (LEXX) stock worth over $23,348. Details can be seen in Thomas James Ihrke's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Thomas James Ihrke has not made any transactions after 2010-12-07 and currently still holds the listed stock(s).
Transaction Summary of Thomas James Ihrke
Thomas James Ihrke Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Thomas James Ihrke owns 2 companies in total, including Lexaria Bioscience Corp (LEXX) , and Enertopia Corp (ENRT) .
Click here to see the complete history of Thomas James Ihrke’s form 4 insider trades.
Insider Ownership Summary of Thomas James Ihrke
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| LEXX | Lexaria Bioscience Corp | 2010-12-07 | Sr. VP & Business Development |
| ENRT | Enertopia Corp | 2010-08-16 | Sr. VP & Business Development |
Thomas James Ihrke Latest Holdings Summary
Thomas James Ihrke currently owns a total of 1 stock. Thomas James Ihrke owns 7,556 shares of Lexaria Bioscience Corp (LEXX) as of December 7, 2010, with a value of $23,348.
Latest Holdings of Thomas James Ihrke
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LEXX | Lexaria Bioscience Corp | 2010-12-07 | 7,556 | 3.09 | 23,348 |
Holding Weightings of Thomas James Ihrke
Thomas James Ihrke Form 4 Trading Tracker
According to the SEC Form 4 filings, Thomas James Ihrke has made a total of 0 transactions in Lexaria Bioscience Corp (LEXX) over the past 5 years. The most-recent trade in Lexaria Bioscience Corp is the acquisition of 1,650 shares on December 7, 2010, which cost Thomas James Ihrke around $9,000.
Insider Trading History of Thomas James Ihrke
- 1
Thomas James Ihrke Trading Performance
GuruFocus tracks the stock performance after each of Thomas James Ihrke's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Thomas James Ihrke is 32.68%. GuruFocus also compares Thomas James Ihrke's trading performance to market benchmark return within the same time period. The performance of stocks bought by Thomas James Ihrke within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Thomas James Ihrke's insider trading performs compared to the benchmark.
Performance of Thomas James Ihrke
Average Return
40.13%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 48.92 | 32.68 | 40.13 | 40.13 | 18.28 | -37.22 |
| Relative Return to S&P 500(%) | 46.81 | 24.47 | 30.81 | 36.23 | 9.9 | -51.17 |
Thomas James Ihrke Ownership Network
Ownership Network List of Thomas James Ihrke
Ownership Network Relation of Thomas James Ihrke
Thomas James Ihrke Owned Company Details
What does Lexaria Bioscience Corp do?
Who are the key executives at Lexaria Bioscience Corp?
Thomas James Ihrke is the Sr. VP & Business Development of Lexaria Bioscience Corp. Other key executives at Lexaria Bioscience Corp include Chief Financial Officer Gregory Downey , director & 10 percent owner & CEO Christopher Bunka , and Secretary Vanessa Carle .
Lexaria Bioscience Corp (LEXX) Insider Trades Summary
Over the past 18 months, Thomas James Ihrke made no insider transaction in Lexaria Bioscience Corp (LEXX). Other recent insider transactions involving Lexaria Bioscience Corp (LEXX) include a net purchase of 1,500 shares made by Catherine C. Turkel ,
In summary, during the past 3 months, insiders sold 0 shares of Lexaria Bioscience Corp (LEXX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Lexaria Bioscience Corp (LEXX) were sold and 1,500 shares were bought by its insiders, resulting in a net purchase of 1,500 shares.
Lexaria Bioscience Corp (LEXX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Lexaria Bioscience Corp Insider Transactions
Thomas James Ihrke Mailing Address
Above is the net worth, insider trading, and ownership report for Thomas James Ihrke. You might contact Thomas James Ihrke via mailing address: 38 Krier Lane, Mount Pleasant Sc 29464.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
